CONTINUE TO SITE

OR WAIT null SECS

Cataract Surgical Case Study Cataract Therapeutics Glaucoma Insights Branded vs Generics CME Activities Dry Eye Viewpoint Diabetic Eye Disease Viewpoints Diabetic Eye Disease Podcast Dry Eye Concepts Management of Dry Eye Viewpoints Ocular Toxicity in Myeloma WetAMD Viewpoints

Clinical

View More Cataract Clinical Diagnosis Cornea Glaucoma IOL OCT Ocular Allergy Ocular Surface Disease Pediatrics Refractive Retina Technology Therapeutic Cataract & Refractive Understanding Antibiotic Resistance

Cataract Clinical Diagnosis Cornea Glaucoma IOL OCT Ocular Allergy Ocular Surface Disease Pediatrics Refractive Retina Technology Therapeutic Cataract & Refractive Understanding Antibiotic Resistance

All News Blogs COVID-19

Expert Interviews Medical World News Podcasts Viewpoints Insights

Health Law & Policy Money Matters Personal Finance Practice Management

Conferences

Conference Coverage

Conference Listing

Conference Coverage Conference Listing

Publications

Digital Edition

Europe Ophthalmology Times

Modern Retina

Supplements and Featured Publications

Digital Edition Europe Ophthalmology Times Modern Retina Supplements and Featured Publications

Ophthalmic solution reformulated as nasal spray for allergies

June 1, 2004

Fort Worth, TX-A nasal formulation of olopatadine HCl ophthalmic solution 0.1% (Patanol, Alcon) reduced seasonal allergic rhinitis symptoms compared with placebo, according to phase III study results.

Related Content:

PediatricsPharmacy

Unlocking the keys to mild COVID-19 cases in infants

Nevakar announces formation of ophthalmic subsidiary, Vyluma

Physician shines spotlight on mass distribution of azithromycin for trachoma control